Prostate Cancer Clinical Trial
The Effects of Radium-223 Dichloride Therapy on Radionuclide Bone Scan Lesions.
Summary
To describe the changes seen on bone scan and correlate them with changes in relative chemical biomarkers, patient's functional status and level of pain.
View Eligibility Criteria
Eligibility Criteria
Inclusion Criteria:
Prostate cancer patients scheduled for treatment with Radium-223.
Exclusion Criteria:
Patients not completing their treatment regimen for any reason
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
Submit
There is 1 Location for this study
See Locations Near You
The University of Texas Health Science Center at Houston
Houston Texas, 77030, United States
Houston Texas, 77030, United States
How clear is this clinincal trial information?